Empowering Pharmacists in the Fight Against Opioid Abuse Act
This bill requires the Drug Enforcement Administration (DEA) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.
The DEA must seek input from relevant stakeholders.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2018-06-13 | IntroReferral | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate |
| 2018-06-12 | Floor | Motion to reconsider laid on the table Agreed to without objection. | House floor actions |
| 2018-06-12 | Floor | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066) | House floor actions |
| 2018-06-12 | Floor | DEBATE - The House proceeded with forty minutes of debate on H.R. 4275. | House floor actions |
| 2018-06-12 | Floor | Considered under suspension of the rules. (consideration: CR H5066-5067) | House floor actions |
| 2018-06-12 | Floor | Mr. Walden moved to suspend the rules and pass the bill, as amended. | House floor actions |
| 2018-05-09 | Committee | Ordered to be Reported (Amended) by Voice Vote. | House committee actions |
| 2018-05-09 | Committee | Committee Consideration and Mark-up Session Held. | House committee actions |
| 2018-04-25 | Committee | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . | House committee actions |
| 2018-04-25 | Committee | Subcommittee Consideration and Mark-up Session Held. | House committee actions |
| 2017-11-10 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2017-11-07 | IntroReferral | Referred to the House Committee on Energy and Commerce. | House floor actions |
| 2017-11-07 | IntroReferral | Introduced in House | Library of Congress |